Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age
Authors:
- Lotte H. HendrikxLHLotte H. Hendrikx
- Mariet K. FelderhofMFMariet K. Felderhof
- Kemal ÖztürkKÖKemal Öztürk
- Lia G.H. de RondLRLia G.H. de Rond
- Marlies A. van HoutenMHMarlies A. van Houten
- Elisabeth A.M. SandersESElisabeth A.M. Sanders
- Guy A.M. BerbersGBGuy A.M. Berbers
- Anne-Marie BuismanABAnne-Marie Buisman
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Pertussis Disease Burden in the Household: How to Protect Young InfantsClinical Infectious Diseases, 2010
- Seroprevalence of pertussis antitoxin (anti‐PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination programAPMIS, 2009
- The utility of seroepidemiology for tracking trends in pertussis infectionEpidemiology and Infection, 2009
- Impact of Acellular Pertussis Preschool Booster Vaccination on Disease Burden of Pertussis in The NetherlandsThe Pediatric Infectious Disease Journal, 2008
- Immunity to Pertussis 5 Years after Booster Immunization during AdolescenceClinical Infectious Diseases, 2007
- Pertussis antitoxin decay after vaccination with DTPaVaccine, 2005
- The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coliProtein Expression and Purification, 2005
- The Epidemiology of Pertussis: A Comparison of the Epidemiology of the Disease Pertussis With the Epidemiology of Bordetella pertussis InfectionPediatrics, 2005
- The seroepidemiology of Bordetella pertussis infection in Western EuropeEpidemiology and Infection, 2004
- Pertussis in the Netherlands: an Outbreak Despite High Levels of Immunization with Whole-Cell VaccineEmerging Infectious Diseases, 1997